BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1684273)

  • 1. Ebastine in perennial allergic rhinitis.
    Picado Vallés C; Cadahia García A; Cisteró Bahima A; Cano Cantudo L; Sanz Amaro A; Zayas Sanza JM
    Ann Allergy; 1991 Dec; 67(6):615-8. PubMed ID: 1684273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis.
    Murris-Espin M; Melac M; Charpentier JC; Didier A
    Ann Allergy Asthma Immunol; 1998 May; 80(5):399-403. PubMed ID: 9609610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
    Sastre J
    Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of the efficacy and tolerability of azelastine nasal spray versus ebastine tablets in patients with seasonal allergic rhinitis].
    Antépara I; Jaúregui I; Basomba A; Cadahia A; Feo F; García JJ; Gonzalo MA; Luna I; Rubio M; Vázquez M
    Allergol Immunopathol (Madr); 1998; 26(1):9-16. PubMed ID: 9585822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults.
    Gehanno P; Bremard-Oury C; Zeisser P
    Ann Allergy Asthma Immunol; 1996 Jun; 76(6):507-12. PubMed ID: 8673684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative clinical studies with ebastine: efficacy and tolerability.
    Luria X
    Drug Saf; 1999; 21 Suppl 1():63-7; discussion 81-7. PubMed ID: 10597869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study.
    Guadaño EM; Serra-Batlles J; Meseguer J; Castillo JA; De Molina M; Valero A; Picado C;
    Allergy; 2004 Jul; 59(7):766-71. PubMed ID: 15180765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study.
    Ratner P; Hampel F; Van Bavel J; Howland W
    Int Arch Allergy Immunol; 2004 Apr; 133(4):371-9. PubMed ID: 15031611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ebastine (kestine 20) in therapy of allergic rhinitis].
    Petrovskaia TIu; Sergeeva TA; Lopatin AS
    Vestn Otorinolaringol; 2007; (3):51-3. PubMed ID: 17768822
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antihistaminics. Side effects also after raising dosage at the placebo level].
    MMW Fortschr Med; 2003 May; 145(22):50-1. PubMed ID: 12866280
    [No Abstract]   [Full Text] [Related]  

  • 11. [In seasonal and perennial rhinitis. Superiority to standard H1 blockers].
    MMW Fortschr Med; 2003 May; 145(22):51. PubMed ID: 12866281
    [No Abstract]   [Full Text] [Related]  

  • 12. A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. Multicentre Study Group.
    Bousquet J; Gaudaño EM; Palma Carlos AG; Staudinger H
    Allergy; 1999 Jun; 54(6):562-8. PubMed ID: 10435469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ebastine vs terfenadine in allergic rhinitis].
    Terán Ortíz L; Flores Sandoval G; Orea Solano M; Camarena A
    Rev Alerg; 1993; 40(4):82-5. PubMed ID: 7908244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ebastine : treatment of perennial rhinitis in the child].
    Benavente V; Eseverri JL; Botey J; Marin A
    Allerg Immunol (Paris); 1996 Oct; 28(8):277-81. PubMed ID: 9011166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebastine increases IFN-gamma production in patients with persistent allergic rhinitis.
    Ciprandi G; Cirillo I; Pistorio A; Di Gioacchino M; Fenoglio D
    J Biol Regul Homeost Agents; 2009; 23(1):31-6. PubMed ID: 19321044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of the skin reaction to histamine by ebastine.
    Nelson HS; Bucher B; Buchmeier A; Oppenheimer J; Garcia J
    Ann Allergy Asthma Immunol; 1995 May; 74(5):442-7. PubMed ID: 7749977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.
    Wiseman LR; Faulds D
    Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consistency of the efficacy of cetirizine and ebastine on skin reactivity.
    Frossard N; Melac M; Benabdesselam O; Pauli G
    Ann Allergy Asthma Immunol; 1998 Jan; 80(1):61-5. PubMed ID: 9475569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihistamines in severe/chronic rhinitis.
    Bousquet J
    Clin Exp Allergy; 1998 Dec; 28 Suppl 6():49-53. PubMed ID: 9988436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical studies of the efficacy and tolerability of ebastine 10 or 20 mg once daily in the treatment of seasonal allergic rhinitis in the US.
    Storms WW
    Drugs; 1996; 52 Suppl 1():20-5. PubMed ID: 8828022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.